Regulatory Review and Analysis of Independent Monitoring Systems
FDA Approves SpringWorks Therapeutics Treatment for Adult and Pediatric Patients with NF1-PN
With the approval, FDA granted SpringWorks a rare pediatric disease priority review voucher.
Drug Solutions Podcast: Forecasting Pharma’s Future
This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.
European Commission Approves BridgeBio Treatment for ATTR-CM
Acoramidis was approved by FDA in November 2024 and is prescribed in the US under the brand name Attruby.
Drug Solutions Podcast: Realizing AI’s Potential
This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.
L.B. Bohle Wet Granulator to Make US Debut at INTERPHEX
The company says it is the pharmaceutical market’s first wet granulator with an integrated, truly continuous dryer.
Scottish Medicines Consortium Accepts AstraZeneca’s Breast Cancer Treatment
While this approval addresses breast cancer, olaparib in combination with durvalumab was approved by the EU in August 2024 for treatment of endometrial cancer.